Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -536 | -339 | -164 | -1,949 | -1,599 |
| Depreciation Amortization | 16 | 12 | 5 | 33 | 24 |
| Other Working Capital | 410 | 223 | 91 | 447 | 287 |
| Other Operating Activity | 35 | 49 | 25 | 1,263 | 1,155 |
| Operating Cash Flow | $-76 | $-55 | $-43 | $-206 | $-133 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 52 | 27 | 25 | 59 | 19 |
| Debt Repayment | -14 | -9 | N/A | -6 | -6 |
| Common Stock Issued | 35 | 35 | 18 | 73 | 41 |
| Other Financing Activity | 3 | 3 | 0 | 73 | 73 |
| Financing Cash Flow | $76 | $55 | $43 | $199 | $127 |
| Beginning Cash Position | N/A | 0 | 0 | 6 | 6 |
| Net Cash Flow | $0 | $0 | $0 | $-6 | $-6 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76 | -55 | -43 | -206 | -133 |
| Free Cash Flow | -76 | -55 | -43 | -206 | -133 |